Rchr
J-GLOBAL ID:200901042954997157   Update date: Apr. 06, 2024

Tsuchiya Norihiko

TSUCHIYA NORIHIKO | Tsuchiya Norihiko
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.id.yamagata-u.ac.jp/Urology/index.html
Research field  (1): Urology
Research keywords  (2): 泌尿器腫瘍学 ,  urologic oncology
Research theme for competitive and other funds  (30):
  • 2022 - 2025 Metabolome analysis for identification of urothelial carcinoma metabotypes and exploration of diagnostic and therapeutic targets
  • 2022 - 2025 泌尿器癌に対する重粒子線治療における免疫学的効果予測因子の探求
  • 2021 - 2025 Molecular mechanisms and target molecules associated with progression and treatment resistance of urologic cancers associated with microbiome alterations by diet and obesity
  • 2019 - 2022 Expression and function analysis of MDSC as a predictive factor of novel immunotherapy with GPI-80
  • 2016 - 2021 Molecular analysis and delineation of the mechanisms underlying progression of urogenital cancers and alteration of tumor immuno-microenvironment associated with adiposity enhancement
Show all
Papers (419):
  • Yuji Takeda, Tomoyuki Kato, Saima Sabrina, Sei Naito, Hiromi Ito, Naoto Emi, Yuya Kuboki, Yuki Takai, Hiroki Fukuhara, Masaki Ushijima, et al. Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin. Biomedicines. 2023. 11. 11
  • Shigemitsu Horie, Sei Naito, Shingo Hatakeyama, Shuya Kandori, Kazuyuki Numakura, Renpei Kato, Tomoyuki Koguchi, Shingo Myoen, Yoshihide Kawasaki, Akihiro Ito, et al. Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group. International journal of clinical oncology. 2023
  • Leandro Blas, Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, et al. Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study. International Journal of Urology. 2023. 30. 9. 788-796
  • Leandro Blas, Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, et al. Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study. International journal of urology : official journal of the Japanese Urological Association. 2023. 30. 9. 788-796
  • Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, et al. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. International journal of clinical oncology. 2023. 28. 5. 726-727
more...
MISC (260):
Books (4):
  • オープンサージャリー
    メジカルビュー社 2019 ISBN:9784758313339
  • Urologic surgery next
    メジカルビュー社 2018
  • ロボット支援手術
    メジカルビュー社 2018 ISBN:9784758313315
  • Hormone Therapy and Castration Resistance of Prostate Cancer
    Springer Singapore 2018
Education (1):
  • - 1988 Akita University School of Medicine
Professional career (1):
  • 医学博士
Work history (4):
  • 2015/11 - 現在 Yamagata University Faculty of Medicine Department of Urology Professor
  • 2004/10 - 2015/10 Akita University School of Medicine Department of Urology Associate Professor
  • 2004/01 - 2004/09 Akita University School of Medicine Department of Urology Lecturer
  • 1996/05 - 2003/12 Akita University School of Medicine Department of Urology Research Assistant
Awards (2):
  • 2014/11 - Japanese Society of Endourology The 4th Japanese Society of Endourology Aso Award Approach to less invasive donor nephrectomy
  • 2007/04 - Japanese Urological Association The 15th Japanese Urological Association Award Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer
Association Membership(s) (15):
Endourological Society ,  Société Internationale d'Urologie ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS ,  Japanese Society of Clinical Renal Transplantation ,  Japan Association of Endocrine surgeons ,  Japan Society of Urologic Oncology ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  American Urological association ,  日本内視鏡外科学会 ,  日本癌治療学会 ,  日本癌学会 ,  THE JAPAN SOCIETY FOR TRANSPLANTATION ,  日本透析医学会 ,  日本泌尿器科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page